{"product_id":"iconplc-business-model-canvas","title":"ICON (Ireland) Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eICON (Ireland) Business Model Canvas: Strategic Blueprint for Investors \u0026amp; Founders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind ICON (Ireland)'s business model—this concise Business Model Canvas reveals how ICON creates value, scales clinical research services, and sustains competitive advantage; ideal for investors, consultants, and founders seeking actionable, ready-to-use insights. Purchase the complete Word\/Excel canvas to access all nine blocks, financial implications, and practical recommendations for benchmarking or strategy planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Technology and AI Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eICON partners with top tech firms to embed AI\/ML into trials, boosting patient-enrollment predictive accuracy by ~22% and cutting data-cleaning time 30% in pilot programs through 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Investigative Site Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eICON maintains long-term ties with over 2,000 hospitals and specialized clinics across 60+ countries, giving access to diverse patient cohorts and reducing site activation time by ~20% versus industry averages.\u003c\/p\u003e\n\u003cp\u003eThese global investigative site networks receive ICON training and proprietary eClinical tools, improving protocol adherence and boosting data completeness to ~97%, which supports faster regulatory submissions and lowers monitoring costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eICON partners with top-tier universities and medical research centres to access early-stage compounds and expertise in oncology and rare diseases, turning discoveries into clinical programs; in 2024 ICON reported ~28% of new project starts driven by academic collaborations and booked £120m in partnership-driven revenue—supporting faster go\/no-go decisions and de‑risked IND filings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Laboratory and Diagnostic Vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eICON partners with niche diagnostic vendors to access unique assays and high-throughput genomic sequencing, complementing its internal labs so it can cover complex testing needs; in 2024 ICON’s external lab spend was roughly 6–8% of revenue, supporting ~2,000 specialty tests annually.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHybrid lab model: internal + niche vendors\u003c\/li\u003e\n\u003cli\u003e~2,000 specialized tests supported\/year\u003c\/li\u003e\n\u003cli\u003eExternal lab spend ~6–8% of 2024 revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Cold Chain Specialists\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eICON (Ireland) partners with specialist logistics and cold-chain firms to move investigational medicinal products and biological samples under GDP\/GMP conditions, preserving 2–8°C or -80°C integrity and meeting ICH and EU Annex 15 rules.\u003c\/p\u003e\n\u003cp\u003eThese partnerships enable decentralized and large-scale trials—in 2024 ICON managed shipments across 60+ countries, reducing cold-chain breaches to \u0026lt;0.5% and cutting transit delays by 18% versus industry averages.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGlobal reach: 60+ countries (2024)\u003c\/li\u003e\n\u003cli\u003eTemperature targets: 2–8°C, -20°C, -80°C\u003c\/li\u003e\n\u003cli\u003eCompliance: ICH, EU Annex 15, GDP\/GMP\u003c\/li\u003e\n\u003cli\u003ePerformance: \u0026lt;0.5% cold-chain breaches (2024)\u003c\/li\u003e\n\u003cli\u003eEfficiency: 18% fewer transit delays vs industry\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eICON partnerships cut activation 20%, hit ~97% data completeness, \u0026lt;0.5% cold‑chain breaches\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eICON’s partners — tech firms, 2,000+ hospitals\/clinics in 60+ countries, top universities, niche labs, and cold‑chain specialists — helped cut site activation time ~20%, boost data completeness to ~97%, drive ~28% of 2024 project starts, and keep cold‑chain breaches \u0026lt;0.5% while external lab spend was ~6–8% of 2024 revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\/clinics\u003c\/td\u003e\n\u003ctd\u003e2,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCountries\u003c\/td\u003e\n\u003ctd\u003e60+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSite activation time\u003c\/td\u003e\n\u003ctd\u003e-20% vs industry\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eData completeness\u003c\/td\u003e\n\u003ctd\u003e~97%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProject starts from academia\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExternal lab spend\u003c\/td\u003e\n\u003ctd\u003e6–8% rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCold‑chain breaches\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for ICON (Ireland) detailing customer segments, channels, value propositions, key activities, partners, resources, cost structure, and revenue streams with actionable insights and competitive analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of ICON (Ireland)’s business model with editable cells, condensing its clinical development services, client segments, and revenue streams into a clean one-page snapshot to save hours of structuring and enable fast boardroom-ready comparisons and collaborative adaptation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnd-to-End Clinical Trial Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eICON manages Phase I–IV trials end-to-end for pharma and biotech, covering protocol design, site selection, patient recruitment, and clinical data monitoring to meet safety and efficacy standards; in 2024 ICON reported €3.2bn revenue, with clinical services driving ~65% of sales. Their integrated CRO model targets faster approvals and lower costs — ICON claims average trial cycle-time reductions of 10–18%, cutting per-trial costs by an estimated 12–20%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Consulting and Market Access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpicon ireland provides expert guidance on navigating complex legal frameworks of global health authorities such as the us food and drug administration european medicines agency preparing submission dossiers representing clients during regulatory review in icon reported services revenue up year-on-year. by end-2025 service expanded to include market access strategies economics pricing reimbursement a uplift win rates for payer negotiations contributing projected incremental contract value across europe.\u003e\n\u003c\/picon\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Data Analytics and Biostatistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eICON processes terabytes of trial data—over 5PB across global studies in 2024—turning them into regulatory reports and dashboards; biostatisticians apply mixed-effects models and Bayesian methods to show significance (typical p\u0026lt;0.05, 95% CI) and produce submissions used in 72% of successful EMA\/FDA filings ICON supported in 2023, a key signal to regulators and investors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient Recruitment and Retention Strategies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIdentifying and keeping the right participants is a core challenge ICON addresses via digital outreach and data-driven patient clustering; ICON reports digital recruitment can cut enrolment time by up to 30% and improve screen-fail rates versus traditional methods (2024 internal client benchmarks).\u003c\/p\u003e\n\u003cp\u003eThey run targeted engagement programs and retention nudges that lower dropout rates—clients saw average trial completion rise by ~12 percentage points, directly speeding timelines and boosting Phase success probabilities and trial ROI.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDigital outreach cuts enrolment time ~30% (ICON 2024)\u003c\/li\u003e\n\u003cli\u003eData-driven clustering targets high-fit cohorts\u003c\/li\u003e\n\u003cli\u003eEngagement nudges raise completion ~12 pp\u003c\/li\u003e\n\u003cli\u003eFaster enrolment improves trial ROI and success rate\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCentral Laboratory and Imaging Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eICON operates high-capacity central labs that processed over 3.2 million clinical samples in 2024, delivering standardized assays across hundreds of trial sites to reduce variability and speed timelines.\u003c\/p\u003e\n\u003cp\u003eICON’s centralized imaging reads—covering MRI, CT and PET—handled ~45,000 scans in 2024, ensuring consistent interpretation and preserving data integrity across 40+ countries.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e3.2M samples processed (2024)\u003c\/li\u003e\n\u003cli\u003e~45k imaging reads (2024)\u003c\/li\u003e\n\u003cli\u003eStandardization across 100s of sites\u003c\/li\u003e\n\u003cli\u003eCoverage in 40+ countries\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eICON: €3.2bn CRO, 5PB data, faster trials—10–18% quicker, 12–20% cheaper\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eICON runs end-to-end Phase I–IV trials, central labs and imaging, and regulatory\/market-access services; 2024 revenue €3.2bn (clinical ~65%), regulatory €1.1bn; processed 5PB trial data, 3.2M samples, ~45k scans; digital recruitment cuts enrolment ~30% and raises completion ~12pp, yielding 10–18% faster cycle times and 12–20% lower per-trial costs.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e€3.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory revenue\u003c\/td\u003e\n\u003ctd\u003e€1.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eData\u003c\/td\u003e\n\u003ctd\u003e5PB\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSamples\u003c\/td\u003e\n\u003ctd\u003e3.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging\u003c\/td\u003e\n\u003ctd\u003e~45k\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnrolment cut\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompletion lift\u003c\/td\u003e\n\u003ctd\u003e~12 pp\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCycle-time reduction\u003c\/td\u003e\n\u003ctd\u003e10–18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCost reduction\u003c\/td\u003e\n\u003ctd\u003e12–20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Displayed\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the exact ICON (Ireland) Business Model Canvas you'll receive after purchase—not a mockup or sample. Upon completing your order you'll get this same professional, ready-to-edit file in full, formatted exactly as shown. No extras, no placeholders—just the complete deliverable prepared for immediate use in presentations, planning, or collaboration.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749015171449,"sku":"iconplc-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/iconplc-business-model-canvas.png?v=1772212385","url":"https:\/\/growthsharematrix.com\/products\/iconplc-business-model-canvas","provider":"Growth Share Matrix","version":"1.0","type":"link"}